REFERENCES
- Arora P, Kolli H, Nainani N, Nader N, Lohr J. Preventable risk factors for acute kidney injury in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2012;26(4):687–697. Epub 2012 Apr 18.
- Davies LK. Cardiopulmonary bypass in infants and children: how is it different? J Cardiothorac Vasc Anesth. 1999;13(3): 330–345.
- Chong Sung K, Kum Suk P, Mi Ja Y, Kyoung Ok K. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial. Acta Anaesthesiol Scand. 2006;50(1):108–111.
- Wyckoff T, Augoustides JG. Advances in acute kidney injury associated with cardiac surgery: the unfolding revolution in early detection. J Cardiothorac Vasc Anesth. 2012;26(2):340–345.
- Herrero-Morin JD, Malaga S, Fernandez N. Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children. Crit Care. 2007;11(3):R59.
- Finney H, Newman DJ, Thakkar H, Fell JM, Price CP. Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child. 2000;82(1):71–75.
- Ogg CS, Cameron JS. Cardiovascular surgery and the kidney. Guys Hosp Rep. 1969;118(1):85–103.
- Chesney RW, Kaplan BS, Freedom RM. Acute renal failure: an important complication of cardiac surgery in infants. J Pediatr. 1975;87(3):381–388.
- Rigden SP, Barrat TM, Dillon MJ. Acute renal failure complicating cardiopulmonary bypass surgery. Arch Dis Child. 1982;57(6):425–430.
- Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest. 1997;112(3):676–692.
- Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 2003;75(2):S715–S720.
- Chenoweth DE, Cooper SW, Hugli TE. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med. 1981;304(9):497–503.
- Mehlhorn U, Davis KL, Burke EJ. Impact of cardiopulmonary bypass and cardioplegic arrest on myocardial lymphatic function. Am J Physiol. 1995;268(1 Pt 2):H178–H183.
- Heltne JK, Bert J, Lund T. Temperature-related fluid extravasation during cardiopulmonary bypass: an analysis of filtration coefficients and transcapillary pressures. Acta Anaesthesiol Scand. 2002;46(1):51–56.
- Base EM, Standl T, Lassnigg A, . Efficacy and safety of hydroxyethyl starch 6% 130/0.4 in a balanced electrolyte solution (Volulyte) during cardiac surgery. J Cardiothorac Vasc Anesth. 2011;25(3):407–414.
- Kuitunen AH, Hynynen MJ, Vahtera E. Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg. 2004;98(2):291–297.
- Rex S, Scholz M, Weyland A. Intra- and extravascular volume status in patients undergoing mitral valve replacement: crystalloid vs. colloid priming of cardiopulmonary bypass. Eur J Anaesthesiol. 2006;23(1):1–9.
- Tollofsrud S, Svennevig JL, Breivik H. Fluid balance and pulmonary functions during and after coronary artery bypass surgery: ringer’s acetate compared with dextran, polygeline, or albumin. Acta Anaesthesiol Scand. 1995;39(5):671–677.
- Tiryakioglu O, Yıldız G, Vural H. Hydroxyethyl starch versus Ringer solution in cardiopulmonary bypass prime solutions (a randomized controlled trial). J Cardiothorac Surg. 2008;3:45.
- Ooi JS, Ramzisham AR, Zamrin MD. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery? Asian Cardiovasc Thorac Ann. 2009;17(4):368–372.
- Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatininee as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40(2):221–226.
- NewmaN DJ, Thakkar H, Edwards RG. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatininee. Kidney Int. 1995;47(1):312–318.
- Galinanes M, Watson C, Trivedi U. Differential patterns of neutrophil adhesion molecules during cardiopulmonary bypass in humans. Circulation. 1996;94(Suppl. 9):II364–II369.
- Rinder CS, Fontes M, Mathew JP. Neutrophil CD11b upregulation during cardiopulmonary bypass is associated with postoperative renal injury. Ann Thorac Surg. 2003;75(3):899–905.
- Iriz E, Kolbakır F, Akar H. Comparison of hydroxyethyl starch and ringer lactate as a prime solution regarding S-100beta protein levels and informative cognitive tests in cerebral injury. Ann Thorac Surg. 2005;79(2):666–671.
- Haneda K, Sato S, Ishizawa E. The importance of colloid osmotic pressure during open heart surgery in infants. Tohoku J Exp Med. 1985;147(1):65–71.
- Aukerman J, Vopel-Lewis T. The relationship between extracorporeal circuit prime, albumin, and postoperative weight gain in children. J Cardiothorac Vasc Anesth. 1998;12(4):408–414.
- Riegger LQ, Voeppel-Lewis T, Kulik TJ. Albumin versus crystalloid prime solution for cardiopulmonary bypass in young children. Crit Care Med. 2002;30(12):2649–2654.
- Loeffelbein F, Zirell U, Benk C. High colloid oncotic pressure priming of cardiopulmonary bypass in neonates and infants: implications on hemofiltration, weight gain and renal function. Eur J Cardiothorac Surg. 2008;34(3):648–652.